Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review

  • ID: 4391477
  • SWOT Analysis
  • 37 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Ambry Genetics Corp
  • Foundation Medicine Inc
  • GeneDX, Inc
  • InVitae Corporation
  • Myriad Genetics Inc
  • MORE
Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians for improving the quality of patient care. The company offers a wide range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. It combines next generation sequencing with its technology platform to offer full-gene sequencing with deletion or duplication analysis in single-gene tests, pre-established, multi-gene, disease-specific panels and customized panels for specific customer needs. The company offers commercial genetic tests for rare paediatric diseases, paediatric tests single-gene tests, and genetic tests for various cardiovascular diseases, neurological disorders, and cancers. Fulgent is headquartered in Temple City, California, the US.

Fulgent Genetics Inc Key Recent Developments

Aug 07,2017: Fulgent Genetics Reports Second Quarter 2017 Financial Results
May 08,2017: Fulgent Genetics Reports First Quarter 2017 Financial Results
Feb 27,2017: Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
Nov 03,2016: Fulgent Genetics Reports Financial Results for the Third Quarter of 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ambry Genetics Corp
  • Foundation Medicine Inc
  • GeneDX, Inc
  • InVitae Corporation
  • Myriad Genetics Inc
  • MORE
Section 1 - About the Company
  • Fulgent Genetics Inc - Key Facts
  • Fulgent Genetics Inc - Key Employees
  • Fulgent Genetics Inc - Key Employee Biographies
  • Fulgent Genetics Inc - Major Products and Services
  • Fulgent Genetics Inc - History
  • Fulgent Genetics Inc - Company Statement
  • Fulgent Genetics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Fulgent Genetics Inc - Business Description
  • Fulgent Genetics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Fulgent Genetics Inc - Strengths
  • Fulgent Genetics Inc - Weaknesses
  • Fulgent Genetics Inc - Opportunities
  • Fulgent Genetics Inc - Threats
  • Fulgent Genetics Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
  • Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
  • Fulgent Genetics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 07, 2017: Fulgent Genetics Reports Second Quarter 2017 Financial Results
  • May 08, 2017: Fulgent Genetics Reports First Quarter 2017 Financial Results
  • Feb 27, 2017: Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
  • Nov 03, 2016: Fulgent Genetics Reports Financial Results for the Third Quarter of 2016
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Fulgent Genetics Inc, Key Facts
  • Fulgent Genetics Inc, Key Employees
  • Fulgent Genetics Inc, Key Employee Biographies
  • Fulgent Genetics Inc, Major Products and Services
  • Fulgent Genetics Inc, History
  • Fulgent Genetics Inc, Subsidiaries
  • Fulgent Genetics Inc, Key Competitors
  • Fulgent Genetics Inc, Ratios based on current share price
  • Fulgent Genetics Inc, Annual Ratios
  • Fulgent Genetics Inc, Annual Ratios (Cont...1)
  • Fulgent Genetics Inc, Interim Ratios
  • Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
  • Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
  • Fulgent Genetics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Fulgent Genetics Inc, Performance Chart (2014 - 2016)
  • Fulgent Genetics Inc, Ratio Charts
  • Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
  • Fulgent Genetics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Ambry Genetics Corp
  • InVitae Corporation
  • Foundation Medicine Inc
  • Myriad Genetics Inc
  • GeneDX, Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll